跳至主要内容
临床试验/NCT03542123
NCT03542123Unknown不适用

Cardiac Output Autonomic Stimulation Therapy for Heart Failure - Hemodynamic Effects

NeuroTronik Inc.1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年6月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
30
试验地点
1
主要终点
Left ventricular pressure and volume

研究概览

简要总结

A single-arm study to observe NeuroTronik Cardiac Autonomic Nerve Stimulation (CANS) Therapy System hemodynamic and other physiologic effects.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Normal sinus rhythm by ECG
  • Men and women 21-75 years old
  • Patients with stable symptomatic heart failure, New York Heart Association (NYHA) class II, III, or IV.

排除标准

  • Systolic Blood Pressure < 90 mmHg or > 160 mmHg
  • Current amiodarone therapy or any other antiarrhythmic therapy
  • Coronary artery bypass graft surgery or percutaneous coronary intervention within prior 1 month
  • Enzyme-positive MI within prior 1 month
  • Patients who have been hospitalized for heart failure and who required the use of HF IV therapy within 30 days before enrollment (measured from release)
  • History of recent severe ventricular arrhythmias
  • Pre-existing carotid artery or cerebral disease
  • Patients with hypertrophic obstructive cardiomyopathy or infiltrative cardiomyopathy (e.g. amyloidosis, sarcoidosis)
  • Patients with prior vagalotomy
  • Patients with current or prior vagal nerve stimulators
  • Subjects with narrow angle glaucoma
  • Renal failure - on dialysis or serum creatinine > 2.0 mg/dl
  • Hepatic failure - bilirubin, SGOT, or SGPT > 4X upper limit of normal
  • Patients with a life expectance < 12 months per physician judgment
  • Women who are pregnant
  • Allergy to fentanyl, midazolam, propofol, eggs, egg products, soybeans, or soy products
  • Subjects unwilling or unable to provide consent for the protocol

研究组 & 干预措施

NeuroTronik CANS Therapy® System

Experimental

干预措施: NeuroTronik CANS Therapy® System (Device)

结局指标

主要结局

Left ventricular pressure and volume

时间窗: One hour

次要结局

  • Heart rate(One hour)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验